These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 37934100)

  • 1. Development of a Model including MRI Features for Predicting Advanced-stage Recurrence of Hepatocellular Carcinoma after Liver Resection.
    Jiang H; Yang C; Chen Y; Wang Y; Wu Y; Chen W; Ronot M; Chernyak V; Fowler KJ; Bashir MR; Song B
    Radiology; 2023 Nov; 309(2):e230527. PubMed ID: 37934100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic MRI features to predict postresection survivals for very early to intermediate stage hepatocellular carcinoma.
    Jiang H; Qin Y; Wei H; Zheng T; Yang T; Wu Y; Ding C; Chernyak V; Ronot M; Fowler KJ; Chen W; Bashir MR; Song B
    Eur Radiol; 2024 May; 34(5):3163-3182. PubMed ID: 37870624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating postsurgical outcomes of patients with a single hepatocellular carcinoma using gadoxetic acid-enhanced MRI: risk scoring system development and validation.
    Park SH; Kim B; Kim S; Park S; Park YH; Shin SK; Sung PS; Choi JI
    Eur Radiol; 2023 May; 33(5):3566-3579. PubMed ID: 36933020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative prediction of cholangiocyte phenotype hepatocellular carcinoma on contrast-enhanced MRI and the prognostic implication after hepatectomy.
    Chen Y; Chen J; Yang C; Wu Y; Wei H; Duan T; Zhang Z; Long L; Jiang H; Song B
    Insights Imaging; 2023 Nov; 14(1):190. PubMed ID: 37962669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatobiliary MR contrast agent uptake as a predictive biomarker of aggressive features on pathology and reduced recurrence-free survival in resectable hepatocellular carcinoma: comparison with dual-tracer 18F-FDG and 18F-FCH PET/CT.
    Mulé S; Chalaye J; Legou F; Tenenhaus A; Calderaro J; Galletto Pregliasco A; Laurent A; Kharrat R; Amaddeo G; Regnault H; Tacher V; Kobeiter H; Itti E; Luciani A
    Eur Radiol; 2020 Oct; 30(10):5348-5357. PubMed ID: 32405753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gadoxetate-enhanced MRI Features of Proliferative Hepatocellular Carcinoma Are Prognostic after Surgery.
    Kang HJ; Kim H; Lee DH; Hur BY; Hwang YJ; Suh KS; Han JK
    Radiology; 2021 Sep; 300(3):572-582. PubMed ID: 34227881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VICT2 Trait: Prognostic Alternative to Peritumoral Hepatobiliary Phase Hypointensity in HCC.
    Jiang H; Wei H; Yang T; Qin Y; Wu Y; Chen W; Shi Y; Ronot M; Bashir MR; Song B
    Radiology; 2023 Apr; 307(2):e221835. PubMed ID: 36786702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and Validation of a Model Including Distinct Vascular Patterns to Estimate Survival in Hepatocellular Carcinoma.
    Lin WP; Xing KL; Fu JC; Ling YH; Li SH; Yu WS; Zhang YF; Zhong C; Wang JH; Chen ZY; Lu LH; Wei W; Guo RP
    JAMA Netw Open; 2021 Sep; 4(9):e2125055. PubMed ID: 34515782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative serum liver enzyme markers for predicting early recurrence after curative resection of hepatocellular carcinoma.
    Wang ZX; Jiang CP; Cao Y; Zhang G; Chen WB; Ding YT
    Hepatobiliary Pancreat Dis Int; 2015 Apr; 14(2):178-85. PubMed ID: 25865691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatobiliary versus Extracellular MRI Contrast Agents in Hepatocellular Carcinoma Detection: Hepatobiliary Phase Features in Relation to Disease-free Survival.
    Kim DK; An C; Chung YE; Choi JY; Lim JS; Park MS; Kim MJ
    Radiology; 2019 Dec; 293(3):594-604. PubMed ID: 31592730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiomic Features at Contrast-enhanced CT Predict Recurrence in Early Stage Hepatocellular Carcinoma: A Multi-Institutional Study.
    Ji GW; Zhu FP; Xu Q; Wang K; Wu MY; Tang WW; Li XC; Wang XH
    Radiology; 2020 Mar; 294(3):568-579. PubMed ID: 31934830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver Imaging-Reporting and Data System treatment response algorithm predicts postsurgical recurrence in locoregional therapy-treated hepatocellular carcinoma.
    Youn SY; Kim B; Kim DH; Choi HJ; Sung PS; Choi JI
    Eur Radiol; 2022 Sep; 32(9):6270-6280. PubMed ID: 35348864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI radiomics based on deep learning automated segmentation to predict early recurrence of hepatocellular carcinoma.
    Wei H; Zheng T; Zhang X; Wu Y; Chen Y; Zheng C; Jiang D; Wu B; Guo H; Jiang H; Song B
    Insights Imaging; 2024 May; 15(1):120. PubMed ID: 38763975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of recurrence and prognosis in patients with hepatocellular carcinoma after resection by use of CLIP score.
    Zhao WH; Ma ZM; Zhou XR; Feng YZ; Fang BS
    World J Gastroenterol; 2002 Apr; 8(2):237-42. PubMed ID: 11925599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Machine Learning Models for Prediction of Posttreatment Recurrence in Early-Stage Hepatocellular Carcinoma Using Pretreatment Clinical and MRI Features: A Proof-of-Concept Study.
    Iseke S; Zeevi T; Kucukkaya AS; Raju R; Gross M; Haider SP; Petukhova-Greenstein A; Kuhn TN; Lin M; Nowak M; Cooper K; Thomas E; Weber MA; Madoff DC; Staib L; Batra R; Chapiro J
    AJR Am J Roentgenol; 2023 Feb; 220(2):245-255. PubMed ID: 35975886
    [No Abstract]   [Full Text] [Related]  

  • 16. Multiphase Liver MRI for Identifying the Macrotrabecular-Massive Subtype of Hepatocellular Carcinoma.
    Mulé S; Galletto Pregliasco A; Tenenhaus A; Kharrat R; Amaddeo G; Baranes L; Laurent A; Regnault H; Sommacale D; Djabbari M; Pigneur F; Tacher V; Kobeiter H; Calderaro J; Luciani A
    Radiology; 2020 Jun; 295(3):562-571. PubMed ID: 32228294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LI-RADS category 5 hepatocellular carcinoma: preoperative gadoxetic acid-enhanced MRI for early recurrence risk stratification after curative resection.
    Wei H; Jiang H; Zheng T; Zhang Z; Yang C; Ye Z; Duan T; Song B
    Eur Radiol; 2021 Apr; 31(4):2289-2302. PubMed ID: 33001306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Models Predict Postsurgical Recurrence and Overall Survival for Patients with Hepatitis B Virus-Related Solitary Hepatocellular Carcinoma ≤10 cm and Without Portal Venous Tumor Thrombus.
    Wang XH; Liao B; Hu WJ; Tu CX; Xiang CL; Hao SH; Mao XH; Qiu XM; Yang XJ; Yue X; Kuang M; Peng BG; Li SQ
    Oncologist; 2020 Oct; 25(10):e1552-e1561. PubMed ID: 32663354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CT Radiomics to Predict Macrotrabecular-Massive Subtype and Immune Status in Hepatocellular Carcinoma.
    Feng Z; Li H; Liu Q; Duan J; Zhou W; Yu X; Chen Q; Liu Z; Wang W; Rong P
    Radiology; 2023 Apr; 307(1):e221291. PubMed ID: 36511807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatobiliary phase hypointense nodule without arterial phase hyperenhancement as a risk factor for late recurrence (>1 year) of hepatocellular carcinoma after surgery.
    Matsuda M; Ichikawa S; Matsuda M; Amemiya H; Ichikawa D; Onishi H; Motosugi U
    Clin Radiol; 2019 Dec; 74(12):975.e1-975.e9. PubMed ID: 31540704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.